Part 2: Immune Thrombocytopenia
Thomas G. DeLoughery, MD, FACP
Professor of Medicine, Pathology, and Pediatrics, Division of Hematology/Medical Oncology, Knight Cancer Center, Departments of Medicine and Pediatrics, and Division of Laboratory Medicine, Department of Pathology, Oregon Health Sciences University, Portland, OR
A 34-year-old man has been treated for ITP with 2 courses of prednisone over the past year. Prednisone therapy raised his platelet count to 75 x 103/ÁL, but with both steroid tapers it decreased to 3 x 103/ÁL. With low platelets, he has suffered increased bruising. Which of the following options is associated with the highest rate of long-term remission?